Next Article in Journal
Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
Next Article in Special Issue
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
Previous Article in Journal
Dysregulation of Gap Junction Function and Cytokine Production in Response to Non-Genotoxic Polycyclic Aromatic Hydrocarbons in an In Vitro Lung Cell Model
Previous Article in Special Issue
Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
 
 
Review

Article Versions Notes

Cancers 2019, 11(4), 573; https://doi.org/10.3390/cancers11040573
Action Date Notes Link
article xml file uploaded 23 April 2019 12:46 CEST Original file -
article xml uploaded. 23 April 2019 12:46 CEST Update https://www.mdpi.com/2072-6694/11/4/573/xml
article pdf uploaded. 23 April 2019 12:46 CEST Version of Record https://www.mdpi.com/2072-6694/11/4/573/pdf
article html file updated 23 April 2019 12:47 CEST Original file -
article html file updated 25 April 2019 07:58 CEST Update -
article html file updated 9 May 2019 20:01 CEST Update -
article html file updated 18 October 2019 20:31 CEST Update -
article html file updated 12 February 2020 07:12 CET Update -
article html file updated 19 July 2022 17:49 CEST Update https://www.mdpi.com/2072-6694/11/4/573/html
Back to TopTop